These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21396199)
1. Evidence for promoting fixed-dose combination drugs in tuberculosis treatment and control: a review. Monedero I; Caminero JA Int J Tuberc Lung Dis; 2011 Apr; 15(4):433-9. PubMed ID: 21396199 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Blomberg B; Spinaci S; Fourie B; Laing R Bull World Health Organ; 2001; 79(1):61-8. PubMed ID: 11217670 [TBL] [Abstract][Full Text] [Related]
4. Review of the Indian market of anti-tuberculosis drugs: focus on the utilisation of rifampicin-based products. Catalani E Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S289-91; discussion S317-21. PubMed ID: 10593707 [TBL] [Abstract][Full Text] [Related]
5. Implementation of fixed-dose combinations in tuberculosis control: outline of responsibilities. Chaulet P Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S353-7; discussion S381-7. PubMed ID: 10593717 [TBL] [Abstract][Full Text] [Related]
6. Is there an increased risk of TB relapse in patients treated with fixed-dose combination drugs in Indonesia? Suryanto AA; van den Broek J; Hatta M; de Soldenhoff R; van der Werf MJ Int J Tuberc Lung Dis; 2008 Feb; 12(2):174-9. PubMed ID: 18230250 [TBL] [Abstract][Full Text] [Related]
7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
8. Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model? Blomberg B; Kitler ME; Milstien J; Dellepiane N; Fanning A; Norval PY; Spinaci S Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S371-80; discussion S381-7. PubMed ID: 10593721 [TBL] [Abstract][Full Text] [Related]
9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
10. Estimate of the global market for rifampicin-containing fixed-dose combination tablets. Norval PY; Blomberg B; Kitler ME; Dye C; Spinaci S Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S292-300; discussion S317-21. PubMed ID: 10593708 [TBL] [Abstract][Full Text] [Related]
11. Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens. Blomberg B; Fourie B Drugs; 2003; 63(6):535-53. PubMed ID: 12656652 [TBL] [Abstract][Full Text] [Related]
13. [Drug resistance in tuberculosis]. Winje BA; Mannsåker T; Langeland N; Heldal E Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2588-92. PubMed ID: 19023372 [TBL] [Abstract][Full Text] [Related]
14. Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption. Ellard GA; Fourie PB Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S301-8; discussion S317-21. PubMed ID: 10593709 [TBL] [Abstract][Full Text] [Related]
15. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up. Su WJ; Perng RP Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151 [TBL] [Abstract][Full Text] [Related]
17. [Research and control of relapse tuberculosis cases]. Yamagishi F; Toyota M Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861 [TBL] [Abstract][Full Text] [Related]